nodes	percent_of_prediction	percent_of_DWPC	metapath
Succinylcholine—BCHE—Alzheimer's disease	0.214	1	CbGaD
Succinylcholine—CHRNE—Galantamine—Alzheimer's disease	0.172	0.267	CbGbCtD
Succinylcholine—CHRNG—Galantamine—Alzheimer's disease	0.172	0.267	CbGbCtD
Succinylcholine—CHRNA10—Galantamine—Alzheimer's disease	0.0871	0.135	CbGbCtD
Succinylcholine—CHRNA1—Galantamine—Alzheimer's disease	0.0531	0.0825	CbGbCtD
Succinylcholine—CHRND—Galantamine—Alzheimer's disease	0.0531	0.0825	CbGbCtD
Succinylcholine—CHRNB1—Galantamine—Alzheimer's disease	0.0531	0.0825	CbGbCtD
Succinylcholine—BCHE—Rivastigmine—Alzheimer's disease	0.0357	0.0554	CbGbCtD
Succinylcholine—BCHE—Galantamine—Alzheimer's disease	0.0184	0.0285	CbGbCtD
Succinylcholine—Fasciculation—Donepezil—Alzheimer's disease	0.00683	0.119	CcSEcCtD
Succinylcholine—Muscle contractions involuntary—Galantamine—Alzheimer's disease	0.00282	0.0492	CcSEcCtD
Succinylcholine—Muscle contractions involuntary—Donepezil—Alzheimer's disease	0.00219	0.0381	CcSEcCtD
Succinylcholine—Muscle contractions involuntary—Memantine—Alzheimer's disease	0.00199	0.0346	CcSEcCtD
Succinylcholine—Muscle contractions involuntary—Rivastigmine—Alzheimer's disease	0.00194	0.0339	CcSEcCtD
Succinylcholine—Muscle rigidity—Rivastigmine—Alzheimer's disease	0.00183	0.032	CcSEcCtD
Succinylcholine—Decamethonium—ACHE—Alzheimer's disease	0.00136	0.63	CrCbGaD
Succinylcholine—Salivary hypersecretion—Galantamine—Alzheimer's disease	0.00132	0.0231	CcSEcCtD
Succinylcholine—Hypertonia—Galantamine—Alzheimer's disease	0.0012	0.0208	CcSEcCtD
Succinylcholine—Apnoea—Memantine—Alzheimer's disease	0.00113	0.0197	CcSEcCtD
Succinylcholine—Apnoea—Rivastigmine—Alzheimer's disease	0.00111	0.0193	CcSEcCtD
Succinylcholine—Salivary hypersecretion—Donepezil—Alzheimer's disease	0.00103	0.0179	CcSEcCtD
Succinylcholine—Respiratory failure—Memantine—Alzheimer's disease	0.000977	0.017	CcSEcCtD
Succinylcholine—Respiratory failure—Rivastigmine—Alzheimer's disease	0.000956	0.0167	CcSEcCtD
Succinylcholine—Hyperkalaemia—Memantine—Alzheimer's disease	0.000943	0.0164	CcSEcCtD
Succinylcholine—Hypertonia—Donepezil—Alzheimer's disease	0.000927	0.0162	CcSEcCtD
Succinylcholine—Salivary hypersecretion—Rivastigmine—Alzheimer's disease	0.000912	0.0159	CcSEcCtD
Succinylcholine—Pulmonary oedema—Memantine—Alzheimer's disease	0.000854	0.0149	CcSEcCtD
Succinylcholine—Hypertonia—Memantine—Alzheimer's disease	0.000841	0.0147	CcSEcCtD
Succinylcholine—Pulmonary oedema—Rivastigmine—Alzheimer's disease	0.000836	0.0146	CcSEcCtD
Succinylcholine—Hypertonia—Rivastigmine—Alzheimer's disease	0.000823	0.0144	CcSEcCtD
Succinylcholine—Decamethonium—BCHE—Alzheimer's disease	0.000799	0.37	CrCbGaD
Succinylcholine—Renal failure acute—Memantine—Alzheimer's disease	0.000755	0.0132	CcSEcCtD
Succinylcholine—Renal failure—Galantamine—Alzheimer's disease	0.00075	0.0131	CcSEcCtD
Succinylcholine—Renal failure acute—Rivastigmine—Alzheimer's disease	0.000738	0.0129	CcSEcCtD
Succinylcholine—Bradycardia—Galantamine—Alzheimer's disease	0.000697	0.0122	CcSEcCtD
Succinylcholine—Cardiac arrest—Memantine—Alzheimer's disease	0.000663	0.0116	CcSEcCtD
Succinylcholine—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.000648	0.0113	CcSEcCtD
Succinylcholine—Flushing—Galantamine—Alzheimer's disease	0.000636	0.0111	CcSEcCtD
Succinylcholine—Arrhythmia—Galantamine—Alzheimer's disease	0.000612	0.0107	CcSEcCtD
Succinylcholine—Bronchospasm—Memantine—Alzheimer's disease	0.000592	0.0103	CcSEcCtD
Succinylcholine—Renal failure—Donepezil—Alzheimer's disease	0.000581	0.0101	CcSEcCtD
Succinylcholine—Bronchospasm—Rivastigmine—Alzheimer's disease	0.000579	0.0101	CcSEcCtD
Succinylcholine—Bradycardia—Donepezil—Alzheimer's disease	0.00054	0.00942	CcSEcCtD
Succinylcholine—Renal failure—Memantine—Alzheimer's disease	0.000528	0.0092	CcSEcCtD
Succinylcholine—Renal failure—Rivastigmine—Alzheimer's disease	0.000516	0.009	CcSEcCtD
Succinylcholine—Hypertension—Galantamine—Alzheimer's disease	0.000515	0.00898	CcSEcCtD
Succinylcholine—Myalgia—Galantamine—Alzheimer's disease	0.000508	0.00885	CcSEcCtD
Succinylcholine—Bradycardia—Memantine—Alzheimer's disease	0.000491	0.00856	CcSEcCtD
Succinylcholine—Bradycardia—Rivastigmine—Alzheimer's disease	0.00048	0.00837	CcSEcCtD
Succinylcholine—Shock—Galantamine—Alzheimer's disease	0.000479	0.00835	CcSEcCtD
Succinylcholine—Tachycardia—Galantamine—Alzheimer's disease	0.000475	0.00828	CcSEcCtD
Succinylcholine—Arrhythmia—Donepezil—Alzheimer's disease	0.000474	0.00827	CcSEcCtD
Succinylcholine—Hypotension—Galantamine—Alzheimer's disease	0.000455	0.00793	CcSEcCtD
Succinylcholine—Flushing—Memantine—Alzheimer's disease	0.000447	0.0078	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000443	0.00773	CcSEcCtD
Succinylcholine—Flushing—Rivastigmine—Alzheimer's disease	0.000438	0.00763	CcSEcCtD
Succinylcholine—Arrhythmia—Memantine—Alzheimer's disease	0.000431	0.00751	CcSEcCtD
Succinylcholine—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000421	0.00734	CcSEcCtD
Succinylcholine—Hypertension—Donepezil—Alzheimer's disease	0.000399	0.00696	CcSEcCtD
Succinylcholine—Myalgia—Donepezil—Alzheimer's disease	0.000393	0.00686	CcSEcCtD
Succinylcholine—Body temperature increased—Galantamine—Alzheimer's disease	0.000385	0.00671	CcSEcCtD
Succinylcholine—Shock—Donepezil—Alzheimer's disease	0.000371	0.00647	CcSEcCtD
Succinylcholine—Hypertension—Memantine—Alzheimer's disease	0.000362	0.00632	CcSEcCtD
Succinylcholine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000359	0.00625	CcSEcCtD
Succinylcholine—Myalgia—Memantine—Alzheimer's disease	0.000357	0.00623	CcSEcCtD
Succinylcholine—Hypertension—Rivastigmine—Alzheimer's disease	0.000354	0.00618	CcSEcCtD
Succinylcholine—Hypotension—Donepezil—Alzheimer's disease	0.000352	0.00614	CcSEcCtD
Succinylcholine—Myalgia—Rivastigmine—Alzheimer's disease	0.000349	0.00609	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000344	0.00599	CcSEcCtD
Succinylcholine—Shock—Memantine—Alzheimer's disease	0.000337	0.00587	CcSEcCtD
Succinylcholine—Tachycardia—Memantine—Alzheimer's disease	0.000334	0.00583	CcSEcCtD
Succinylcholine—Shock—Rivastigmine—Alzheimer's disease	0.00033	0.00575	CcSEcCtD
Succinylcholine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000327	0.0057	CcSEcCtD
Succinylcholine—Hypotension—Memantine—Alzheimer's disease	0.00032	0.00558	CcSEcCtD
Succinylcholine—Hypotension—Rivastigmine—Alzheimer's disease	0.000313	0.00546	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000312	0.00544	CcSEcCtD
Succinylcholine—Rash—Galantamine—Alzheimer's disease	0.000307	0.00535	CcSEcCtD
Succinylcholine—Dermatitis—Galantamine—Alzheimer's disease	0.000307	0.00535	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000305	0.00532	CcSEcCtD
Succinylcholine—Urticaria—Donepezil—Alzheimer's disease	0.0003	0.00522	CcSEcCtD
Succinylcholine—Body temperature increased—Donepezil—Alzheimer's disease	0.000298	0.0052	CcSEcCtD
Succinylcholine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000278	0.00484	CcSEcCtD
Succinylcholine—Urticaria—Memantine—Alzheimer's disease	0.000272	0.00474	CcSEcCtD
Succinylcholine—Body temperature increased—Memantine—Alzheimer's disease	0.000271	0.00472	CcSEcCtD
Succinylcholine—Urticaria—Rivastigmine—Alzheimer's disease	0.000266	0.00464	CcSEcCtD
Succinylcholine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000265	0.00462	CcSEcCtD
Succinylcholine—Hypersensitivity—Memantine—Alzheimer's disease	0.000252	0.0044	CcSEcCtD
Succinylcholine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000247	0.0043	CcSEcCtD
Succinylcholine—Rash—Donepezil—Alzheimer's disease	0.000238	0.00415	CcSEcCtD
Succinylcholine—Dermatitis—Donepezil—Alzheimer's disease	0.000238	0.00414	CcSEcCtD
Succinylcholine—Rash—Memantine—Alzheimer's disease	0.000216	0.00376	CcSEcCtD
Succinylcholine—Dermatitis—Memantine—Alzheimer's disease	0.000216	0.00376	CcSEcCtD
Succinylcholine—Rash—Rivastigmine—Alzheimer's disease	0.000211	0.00368	CcSEcCtD
Succinylcholine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000211	0.00368	CcSEcCtD
Succinylcholine—CHRM2—forebrain—Alzheimer's disease	6.75e-05	0.0707	CbGeAlD
Succinylcholine—CHRM2—telencephalon—Alzheimer's disease	6.2e-05	0.065	CbGeAlD
Succinylcholine—CHRM1—forebrain—Alzheimer's disease	6.14e-05	0.0644	CbGeAlD
Succinylcholine—CHRNA1—brain—Alzheimer's disease	5.66e-05	0.0593	CbGeAlD
Succinylcholine—CHRM1—telencephalon—Alzheimer's disease	5.65e-05	0.0592	CbGeAlD
Succinylcholine—CHRM3—forebrain—Alzheimer's disease	5.49e-05	0.0576	CbGeAlD
Succinylcholine—CHRNB1—cerebellum—Alzheimer's disease	5.38e-05	0.0563	CbGeAlD
Succinylcholine—CHRM3—telencephalon—Alzheimer's disease	5.05e-05	0.053	CbGeAlD
Succinylcholine—BCHE—forebrain—Alzheimer's disease	4.48e-05	0.047	CbGeAlD
Succinylcholine—CHRNB1—brain—Alzheimer's disease	4.37e-05	0.0458	CbGeAlD
Succinylcholine—BCHE—telencephalon—Alzheimer's disease	4.12e-05	0.0432	CbGeAlD
Succinylcholine—CHRM2—nervous system—Alzheimer's disease	3.66e-05	0.0384	CbGeAlD
Succinylcholine—CHRM2—central nervous system—Alzheimer's disease	3.53e-05	0.0369	CbGeAlD
Succinylcholine—CHRM1—nervous system—Alzheimer's disease	3.33e-05	0.0349	CbGeAlD
Succinylcholine—CHRM1—central nervous system—Alzheimer's disease	3.21e-05	0.0336	CbGeAlD
Succinylcholine—CHRM3—nervous system—Alzheimer's disease	2.98e-05	0.0313	CbGeAlD
Succinylcholine—CHRM3—central nervous system—Alzheimer's disease	2.87e-05	0.0301	CbGeAlD
Succinylcholine—CHRM2—brain—Alzheimer's disease	2.8e-05	0.0293	CbGeAlD
Succinylcholine—CHRM1—brain—Alzheimer's disease	2.55e-05	0.0267	CbGeAlD
Succinylcholine—BCHE—nervous system—Alzheimer's disease	2.43e-05	0.0255	CbGeAlD
Succinylcholine—BCHE—central nervous system—Alzheimer's disease	2.34e-05	0.0246	CbGeAlD
Succinylcholine—BCHE—cerebellum—Alzheimer's disease	2.29e-05	0.024	CbGeAlD
Succinylcholine—CHRM3—brain—Alzheimer's disease	2.28e-05	0.0239	CbGeAlD
Succinylcholine—BCHE—brain—Alzheimer's disease	1.86e-05	0.0195	CbGeAlD
Succinylcholine—CHRM2—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	7.83e-06	9.62e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—APP—Alzheimer's disease	7.8e-06	9.59e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR ligand binding—CCL2—Alzheimer's disease	7.79e-06	9.57e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PTGS1—Alzheimer's disease	7.79e-06	9.57e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—ENO1—Alzheimer's disease	7.79e-06	9.57e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR ligand binding—CCL2—Alzheimer's disease	7.77e-06	9.54e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR ligand binding—CCL2—Alzheimer's disease	7.69e-06	9.45e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PSENEN—Alzheimer's disease	7.65e-06	9.39e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—CYP2D6—Alzheimer's disease	7.64e-06	9.38e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PSENEN—Alzheimer's disease	7.62e-06	9.36e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—GAPDH—Alzheimer's disease	7.61e-06	9.35e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PSENEN—Alzheimer's disease	7.55e-06	9.27e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—APH1A—Alzheimer's disease	7.54e-06	9.26e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—APH1A—Alzheimer's disease	7.52e-06	9.23e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PLCB1—Alzheimer's disease	7.46e-06	9.17e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—APH1A—Alzheimer's disease	7.44e-06	9.14e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PLCB1—Alzheimer's disease	7.44e-06	9.14e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PLCB1—Alzheimer's disease	7.36e-06	9.05e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—A2M—Alzheimer's disease	7.35e-06	9.03e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NCSTN—Alzheimer's disease	7.34e-06	9.02e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NCSTN—Alzheimer's disease	7.32e-06	8.99e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NCSTN—Alzheimer's disease	7.25e-06	8.9e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism of proteins—INS—Alzheimer's disease	7.22e-06	8.87e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—LRP1—Alzheimer's disease	7.16e-06	8.8e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—LRP1—Alzheimer's disease	7.14e-06	8.77e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism of proteins—CCL2—Alzheimer's disease	7.1e-06	8.73e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Circadian rythm related genes—TP53—Alzheimer's disease	7.07e-06	8.69e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—LRP1—Alzheimer's disease	7.07e-06	8.68e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—GFAP—Alzheimer's disease	6.99e-06	8.59e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—GAL—Alzheimer's disease	6.99e-06	8.59e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism of proteins—IGF1—Alzheimer's disease	6.98e-06	8.58e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—GFAP—Alzheimer's disease	6.97e-06	8.56e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—GAL—Alzheimer's disease	6.97e-06	8.56e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—GAL—Alzheimer's disease	6.9e-06	8.48e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—GFAP—Alzheimer's disease	6.9e-06	8.48e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PLCB1—Alzheimer's disease	6.83e-06	8.39e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	6.7e-06	8.23e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—ABCA1—Alzheimer's disease	6.62e-06	8.14e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Circadian rythm related genes—IL6—Alzheimer's disease	6.48e-06	7.96e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—ACHE—Alzheimer's disease	6.39e-06	7.85e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—INPP5D—Alzheimer's disease	6.32e-06	7.76e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—A2M—Alzheimer's disease	6.16e-06	7.57e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—A2M—Alzheimer's disease	6.14e-06	7.55e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	6.14e-06	7.54e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	6.12e-06	7.51e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—A2M—Alzheimer's disease	6.08e-06	7.47e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—PRKCG—Alzheimer's disease	6.08e-06	7.46e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—PRKCG—Alzheimer's disease	6.06e-06	7.44e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—PRKCG—Alzheimer's disease	6e-06	7.37e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—ENO1—Alzheimer's disease	5.99e-06	7.36e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PTGS1—Alzheimer's disease	5.99e-06	7.36e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PSEN2—Alzheimer's disease	5.97e-06	7.33e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PSEN2—Alzheimer's disease	5.95e-06	7.31e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PSEN2—Alzheimer's disease	5.89e-06	7.24e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CYP2D6—Alzheimer's disease	5.87e-06	7.22e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—CCR5—Alzheimer's disease	5.76e-06	7.07e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—CCR5—Alzheimer's disease	5.74e-06	7.05e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PPARGC1A—Alzheimer's disease	5.71e-06	7.01e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—CCR5—Alzheimer's disease	5.68e-06	6.98e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—HMOX1—Alzheimer's disease	5.68e-06	6.98e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—HTR2A—Alzheimer's disease	5.63e-06	6.92e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—HTR2A—Alzheimer's disease	5.62e-06	6.9e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—BCHE—Alzheimer's disease	5.57e-06	6.84e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—HTR2A—Alzheimer's disease	5.56e-06	6.83e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PRKCG—Alzheimer's disease	5.52e-06	6.78e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PRKCG—Alzheimer's disease	5.5e-06	6.76e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NPY—Alzheimer's disease	5.49e-06	6.75e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NPY—Alzheimer's disease	5.48e-06	6.73e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IAPP—Alzheimer's disease	5.46e-06	6.71e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PRKCG—Alzheimer's disease	5.45e-06	6.69e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IAPP—Alzheimer's disease	5.44e-06	6.69e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NPY—Alzheimer's disease	5.42e-06	6.66e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IAPP—Alzheimer's disease	5.39e-06	6.62e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CRH—Alzheimer's disease	5.3e-06	6.51e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CRH—Alzheimer's disease	5.28e-06	6.49e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PLCB1—Alzheimer's disease	5.25e-06	6.45e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CRH—Alzheimer's disease	5.23e-06	6.43e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CCR5—Alzheimer's disease	5.23e-06	6.42e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CCR5—Alzheimer's disease	5.21e-06	6.4e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—LPL—Alzheimer's disease	5.2e-06	6.38e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CCR5—Alzheimer's disease	5.16e-06	6.34e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—HTR2A—Alzheimer's disease	5.12e-06	6.29e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—HTR2A—Alzheimer's disease	5.1e-06	6.27e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—ABCA1—Alzheimer's disease	5.09e-06	6.26e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—HTR2A—Alzheimer's disease	5.05e-06	6.21e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NPS—Alzheimer's disease	5.02e-06	6.17e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NPS—Alzheimer's disease	5.01e-06	6.15e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PPP3CA—Alzheimer's disease	5e-06	6.14e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PPP3CA—Alzheimer's disease	4.98e-06	6.12e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NPS—Alzheimer's disease	4.96e-06	6.09e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—F2—Alzheimer's disease	4.94e-06	6.07e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PPP3CA—Alzheimer's disease	4.93e-06	6.06e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PTK2B—Alzheimer's disease	4.93e-06	6.05e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—F2—Alzheimer's disease	4.92e-06	6.05e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PTK2B—Alzheimer's disease	4.91e-06	6.03e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—F2—Alzheimer's disease	4.88e-06	5.99e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PTK2B—Alzheimer's disease	4.86e-06	5.98e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—GAB2—Alzheimer's disease	4.79e-06	5.89e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—SST—Alzheimer's disease	4.79e-06	5.89e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NTRK2—Alzheimer's disease	4.79e-06	5.89e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—SST—Alzheimer's disease	4.78e-06	5.87e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—GAB2—Alzheimer's disease	4.78e-06	5.87e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NTRK2—Alzheimer's disease	4.78e-06	5.87e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CALM1—Alzheimer's disease	4.77e-06	5.86e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CALM1—Alzheimer's disease	4.76e-06	5.85e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—GSK3A—Alzheimer's disease	4.75e-06	5.84e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—GSK3A—Alzheimer's disease	4.74e-06	5.82e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—SST—Alzheimer's disease	4.73e-06	5.81e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—GAB2—Alzheimer's disease	4.73e-06	5.81e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NTRK2—Alzheimer's disease	4.73e-06	5.81e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CALM1—Alzheimer's disease	4.71e-06	5.79e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—GSK3A—Alzheimer's disease	4.69e-06	5.76e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—MTHFR—Alzheimer's disease	4.68e-06	5.75e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—APP—Alzheimer's disease	4.67e-06	5.74e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—APP—Alzheimer's disease	4.66e-06	5.72e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—APP—Alzheimer's disease	4.61e-06	5.66e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—F2—Alzheimer's disease	4.49e-06	5.51e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—F2—Alzheimer's disease	4.47e-06	5.49e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—F2—Alzheimer's disease	4.43e-06	5.44e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PLCB1—Alzheimer's disease	4.41e-06	5.41e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PLCB1—Alzheimer's disease	4.39e-06	5.4e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PPARGC1A—Alzheimer's disease	4.39e-06	5.39e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—CALM1—Alzheimer's disease	4.37e-06	5.37e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—HMOX1—Alzheimer's disease	4.37e-06	5.37e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—APOE—Alzheimer's disease	4.36e-06	5.35e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PLCB1—Alzheimer's disease	4.35e-06	5.35e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—CAV1—Alzheimer's disease	4.32e-06	5.3e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NGFR—Alzheimer's disease	4.11e-06	5.05e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NGFR—Alzheimer's disease	4.1e-06	5.04e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CREB1—Alzheimer's disease	4.09e-06	5.02e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CREB1—Alzheimer's disease	4.07e-06	5e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NGFR—Alzheimer's disease	4.06e-06	4.99e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CREB1—Alzheimer's disease	4.03e-06	4.96e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—ADAM10—Alzheimer's disease	4.02e-06	4.93e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—ADAM10—Alzheimer's disease	4e-06	4.92e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CCL2—Alzheimer's disease	4e-06	4.91e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—LPL—Alzheimer's disease	4e-06	4.91e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CCL2—Alzheimer's disease	3.99e-06	4.9e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—ADAM10—Alzheimer's disease	3.96e-06	4.87e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CCL2—Alzheimer's disease	3.95e-06	4.85e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—S100B—Alzheimer's disease	3.8e-06	4.67e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PPARG—Alzheimer's disease	3.79e-06	4.66e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—S100B—Alzheimer's disease	3.79e-06	4.65e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—S100B—Alzheimer's disease	3.75e-06	4.61e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—INS—Alzheimer's disease	3.72e-06	4.57e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IGF2—Alzheimer's disease	3.62e-06	4.44e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IGF2—Alzheimer's disease	3.6e-06	4.43e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—MTHFR—Alzheimer's disease	3.6e-06	4.42e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IGF2—Alzheimer's disease	3.57e-06	4.39e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IGF1R—Alzheimer's disease	3.5e-06	4.3e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IGF1R—Alzheimer's disease	3.49e-06	4.28e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IGF1R—Alzheimer's disease	3.45e-06	4.24e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CALM1—Alzheimer's disease	3.36e-06	4.13e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—LPL—Alzheimer's disease	3.35e-06	4.12e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—APOE—Alzheimer's disease	3.35e-06	4.12e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—LPL—Alzheimer's disease	3.34e-06	4.11e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MEF2C—Alzheimer's disease	3.32e-06	4.08e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CAV1—Alzheimer's disease	3.32e-06	4.08e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MEF2C—Alzheimer's disease	3.31e-06	4.07e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—LPL—Alzheimer's disease	3.31e-06	4.07e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MEF2C—Alzheimer's disease	3.28e-06	4.03e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—NOS3—Alzheimer's disease	3.26e-06	4.01e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PRKCG—Alzheimer's disease	3.26e-06	4e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PRKCG—Alzheimer's disease	3.25e-06	3.99e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PRKCG—Alzheimer's disease	3.22e-06	3.95e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NGF—Alzheimer's disease	3.17e-06	3.9e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NGF—Alzheimer's disease	3.16e-06	3.89e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NGF—Alzheimer's disease	3.13e-06	3.85e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CCR5—Alzheimer's disease	3.09e-06	3.79e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CCR5—Alzheimer's disease	3.08e-06	3.78e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CCR5—Alzheimer's disease	3.05e-06	3.75e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—HTR2A—Alzheimer's disease	3.02e-06	3.71e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—HTR2A—Alzheimer's disease	3.01e-06	3.7e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PTGS2—Alzheimer's disease	2.98e-06	3.67e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—HTR2A—Alzheimer's disease	2.98e-06	3.67e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PPARG—Alzheimer's disease	2.92e-06	3.58e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—INS—Alzheimer's disease	2.86e-06	3.52e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CALM1—Alzheimer's disease	2.82e-06	3.46e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CALM1—Alzheimer's disease	2.81e-06	3.45e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—LEP—Alzheimer's disease	2.81e-06	3.45e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—APOE—Alzheimer's disease	2.81e-06	3.45e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—LEP—Alzheimer's disease	2.8e-06	3.44e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—APOE—Alzheimer's disease	2.8e-06	3.44e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CAV1—Alzheimer's disease	2.78e-06	3.42e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CALM1—Alzheimer's disease	2.78e-06	3.42e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CAV1—Alzheimer's disease	2.78e-06	3.41e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—APOE—Alzheimer's disease	2.77e-06	3.41e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—LEP—Alzheimer's disease	2.77e-06	3.41e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CAV1—Alzheimer's disease	2.75e-06	3.38e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—ESR1—Alzheimer's disease	2.68e-06	3.3e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—ESR1—Alzheimer's disease	2.67e-06	3.29e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—F2—Alzheimer's disease	2.65e-06	3.26e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—ESR1—Alzheimer's disease	2.65e-06	3.25e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—F2—Alzheimer's disease	2.64e-06	3.25e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—F2—Alzheimer's disease	2.62e-06	3.21e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	2.59e-06	3.19e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NOTCH1—Alzheimer's disease	2.58e-06	3.18e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NOTCH1—Alzheimer's disease	2.56e-06	3.14e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—NOS3—Alzheimer's disease	2.51e-06	3.08e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—GSK3B—Alzheimer's disease	2.43e-06	2.99e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—GSK3B—Alzheimer's disease	2.43e-06	2.98e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CREB1—Alzheimer's disease	2.41e-06	2.97e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CREB1—Alzheimer's disease	2.41e-06	2.96e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	2.4e-06	2.95e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—INS—Alzheimer's disease	2.4e-06	2.95e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—INS—Alzheimer's disease	2.39e-06	2.94e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	2.38e-06	2.93e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—INS—Alzheimer's disease	2.37e-06	2.91e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CCL2—Alzheimer's disease	2.36e-06	2.9e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CCL2—Alzheimer's disease	2.35e-06	2.89e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	2.33e-06	2.86e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	2.32e-06	2.85e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IGF1—Alzheimer's disease	2.31e-06	2.84e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PTGS2—Alzheimer's disease	2.3e-06	2.82e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	2.29e-06	2.82e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	2.11e-06	2.59e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NOS3—Alzheimer's disease	2.1e-06	2.58e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	2.08e-06	2.55e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.8e-06	2.22e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—AKT1—Alzheimer's disease	1.8e-06	2.21e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	1.79e-06	2.2e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CASP3—Alzheimer's disease	1.78e-06	2.19e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.78e-06	2.19e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	1.78e-06	2.18e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—IL6—Alzheimer's disease	1.77e-06	2.17e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	1.76e-06	2.17e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	1.75e-06	2.15e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	1.64e-06	2.02e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	1.64e-06	2.01e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MAPK8—Alzheimer's disease	1.64e-06	2.01e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—AKT1—Alzheimer's disease	1.63e-06	2.01e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	1.62e-06	1.99e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	1.62e-06	1.99e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	1.52e-06	1.86e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—VEGFA—Alzheimer's disease	1.51e-06	1.86e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—AKT1—Alzheimer's disease	1.5e-06	1.84e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	1.5e-06	1.84e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	1.39e-06	1.71e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TGFB1—Alzheimer's disease	1.39e-06	1.7e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	1.37e-06	1.69e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—AKT1—Alzheimer's disease	1.15e-06	1.42e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	1.15e-06	1.41e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TP53—Alzheimer's disease	1.14e-06	1.4e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	1.13e-06	1.39e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	1.05e-06	1.29e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IL6—Alzheimer's disease	1.05e-06	1.28e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	1.04e-06	1.27e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	9.68e-07	1.19e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—AKT1—Alzheimer's disease	9.65e-07	1.19e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	9.55e-07	1.17e-05	CbGpPWpGaD
